Citação norma APA

Mesa, R., Hudgens, S., Floden, L., Harrison, C., Palmer, J., Gupta, V., . . . Verstovsek, S. (2023). Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies. Wiley.

Citação norma Chicago

Mesa, RA, et al. Symptomatic Benefit of Momelotinib in Patients with Myelofibrosis: Results from the SIMPLIFY Phase III Studies. Wiley, 2023.

Citação norma MLA

Mesa, RA, et al. Symptomatic Benefit of Momelotinib in Patients with Myelofibrosis: Results from the SIMPLIFY Phase III Studies. Wiley, 2023.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.